Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update

Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the sub...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 28; no. 8; pp. 794 - 810
Main Author Elpek, Gulsum Ozlem
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin.
AbstractList Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin.
Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin.Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms of diagnosis and treatment. Over the years, the diagnostic criteria, classification, and clinical behavior of these tumors have been the subjects of ongoing debate, and the various changes in their nomenclature have strengthened the challenges associated with MiNENs. This review is performed to provide an understanding of the key factors involved in the evolution of the designation of these tumors as MiNEN, highlight the current diagnostic criteria, summarize the latest data on pathogenesis and provide information on available treatments. Moreover, this work seeks to increase the awareness about these rare neoplasms by presenting the clinicopathological features and prognostic factors that play important roles in their behavior and discussing their different regions of origin in the gastrointestinal system (GIS). Currently, the MiNEN category also includes tumors in the GIS with a nonneuroendocrine component and epithelial tumors other than adenocarcinoma, depending on the organ of origin. Diagnosis is based on the presence of both morphological components in more than 30% of the tumor. However, this value needs to be reconfirmed with further studies and may be a limiting factor in the diagnosis of MiNEN by biopsy. Furthermore, available clinicopathological data suggest that the inclusion of amphicrine tumors in the definition of MiNEN is not supportive and warrants further investigation. The diagnosis of these tumors is not solely based on immunohistochemical findings. They are not hybrid tumors and both components can act independently; thus, careful grading of each component separately is required. In addition to parameters such as the metastatic state of the tumor at the time of diagnosis and the feasibility of surgical resection, the aggressive potential of both components has paramount importance in the choice of treatment. Regardless of the organ of origin within the GIS, almost MiNENs are tumors with poor prognosis and are frequently encountered in the elderly and men. They are most frequently reported in the colorectum, where data from molecular studies indicate a monoclonal origin; however, further studies are required to provide additional support for this origin.
Author Elpek, Gulsum Ozlem
Author_xml – sequence: 1
  givenname: Gulsum Ozlem
  surname: Elpek
  fullname: Elpek, Gulsum Ozlem
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35317101$$D View this record in MEDLINE/PubMed
BookMark eNp1UctO3TAQtSpQudBuu0RZsknwK4ndBRJCfSCB2LCsZDnO5GKU2BfbgbLjH_jDfklN7wVBJVYjzZzHzJxdtOW8A4S-EFyxlovDu-tldUtFZUXVSv4BLSglsqSC4y20IBi3pWS03UG7MV5jTBmr6Ue0w2pGWoLJAv06t7-hLxzMwYPrvQnWwZ-Hx2zztpchfjXqOMXCD0W6gmKpYwreugQxWafHIt7HBNPX4tgV86rXCT6h7UGPET5v6h66_P7t8uRneXbx4_Tk-Kw0TOJUdp2UtJGcsaY1YhANgGkoGXTNjOBDJ7qG5hHIRgPXjJu6yX1CCen6mmG2h47Wsqu5m6A34FLQo1oFO-lwr7y26u3E2Su19LdKSIzrlmeBg41A8DdzPkdNNhoYR52PnqOiDaeMCvoPuv_a68Xk-aMZUK0BJvgYAwwvEILVU2QqR6ZyZMoKlSPLBP4fwdikk_VPu9rxPdpfbjCgLQ
CitedBy_id crossref_primary_10_17235_reed_2023_9988_2023
crossref_primary_10_1093_jscr_rjae026
crossref_primary_10_1093_jscr_rjae612
crossref_primary_10_1186_s40792_023_01689_6
crossref_primary_10_1159_000539978
crossref_primary_10_1097_RCT_0000000000001541
crossref_primary_10_3389_fonc_2024_1335760
crossref_primary_10_1159_000538384
crossref_primary_10_22516_25007440_903
crossref_primary_10_3919_jjsa_85_927
crossref_primary_10_4251_wjgo_v16_i6_2295
crossref_primary_10_1177_20363613241242383
crossref_primary_10_1016_j_modpat_2024_100566
crossref_primary_10_1515_biol_2022_0774
crossref_primary_10_3390_cancers17071074
crossref_primary_10_4251_wjgo_v16_i12_4559
crossref_primary_10_1016_j_asjsur_2023_04_098
crossref_primary_10_12998_wjcc_v10_i27_9573
crossref_primary_10_7759_cureus_63141
Cites_doi 10.1186/s13000-019-0815-3
10.1530/ERC-14-0410
10.1007/s00428-012-1212-4
10.1159/000501200
10.1186/s12957-021-02187-5
10.1186/s12935-019-1031-7
10.1097/MD.0000000000023271
10.1001/jamanetworkopen.2021.14180
10.1097/MD.0000000000002156
10.1038/modpathol.2016.220
10.1186/s12967-020-02293-0
10.1007/978-3-642-59655-1
10.1097/PAS.0b013e31826399d8
10.1158/2159-8290.CD-14-0617
10.1097/01.pas.0000157974.05397.4f
10.1177/106689690401200204
10.1245/s10434-014-3725-3
10.3390/medsci9030047
10.3390/jcm9010273
10.21037/jgo.2018.11.08
10.1530/ERC-17-0557
10.1007/s12328-019-01009-2
10.1002/dc.23107
10.1002/path.5556
10.14670/HH-18-045
10.17235/reed.2016.4315/2016
10.1136/jcp.46.2.183
10.1016/s0002-9440(10)64917-6
10.1038/modpathol.2016.150
10.1186/s40792-021-01152-4
10.3748/wjg.v21.i41.11740
10.1016/j.ejso.2019.08.002
10.1097/PAS.0000000000000169
10.1016/S0140-6736(15)00817-X
10.3389/fonc.2016.00148
10.32074/1591-951X-230
10.1097/MD.0000000000027348
10.1111/pin.12029
10.1093/ajcp/aqw028
10.18632/oncotarget.18678
10.1177/0003134820950000
10.1097/MPA.0b013e318264d073
10.1016/j.pan.2020.11.020
10.1056/NEJMoa1316158
10.1186/s40792-018-0454-z
10.3389/fonc.2021.709097
10.1016/j.pathol.2020.01.437
10.1016/j.dld.2011.07.010
10.1002/cncr.22179
10.1111/his.13975
10.1007/s00428-018-2366-5
10.1007/s00535-020-01756-x
10.1007/s00428-012-1348-2
10.1016/j.prp.2021.153593
10.1038/s41598-018-37707-z
10.1002/cam4.4031
10.3389/fsurg.2021.678853
10.1016/j.humpath.2020.12.008
10.3748/wjg.v27.i7.624
10.1056/NEJMoa1607427
10.14309/crj.2018.39
10.1007/s005950300048
10.1186/s12893-019-0546-0
10.1007/s12328-021-01420-8
10.3748/wjg.v25.i39.5991
10.2169/internalmedicine.4609-20
10.1159/000443612
10.1016/j.jcma.2015.04.002
10.1007/s12328-015-0623-6
10.1177/000313482008600224
10.1177/1066896917752443
10.1016/j.humpath.2017.08.036
10.1007/s12022-018-9522-y
10.1016/j.humpath.2017.12.009
10.1016/S1590-8658(16)30195-5
10.1002/1097-0142(19810801)48:3<833::aid-cncr2820480328>3.0.co;2-z
10.1080/0284186X.2021.1903077
10.14740/gr1323
10.1002/cncr.28721
10.1016/S1726-4901(09)70400-9
10.1111/1751-2980.12752
10.1186/s12957-017-1157-9
10.5230/jgc.2018.18.e16
10.1016/j.prp.2020.152869
10.3389/fonc.2020.01660
10.1007/s12022-020-09605-6
10.1016/j.ejso.2020.08.022
10.1111/his.14178
10.1007/s12022-016-9432-9
10.3390/cancers4010011
10.1016/s0242-6498(05)86164-4
10.1038/s41379-021-00978-5
10.1097/01.lab.0000079006.91414.be
10.1016/j.critrevonc.2019.02.012
10.1007/s00795-021-00294-6
10.1007/978-3-319-17235-4
10.2152/jmi.52.191
10.1200/PO.20.00487
10.3389/fmed.2015.00041
10.4274/balkanmedj.2017.1471
10.1016/j.ejso.2021.05.021
10.1007/s100249910040
10.1016/j.ejca.2014.08.004
10.1016/j.ando.2019.04.006
10.1136/bcr-2020-234855
10.1159/000369071
10.1159/000375449
10.1097/PAI.0000000000000969
ContentType Journal Article
Copyright The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. 2022
Copyright_xml – notice: The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
– notice: The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v28.i8.794
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Elpek GO. MiNENs of the gastrointestinal system
EISSN 2219-2840
EndPage 810
ExternalDocumentID PMC8900574
35317101
10_3748_wjg_v28_i8_794
Genre Journal Article
Review
GroupedDBID ---
123
29R
2WC
36B
53G
5VR
8WL
AAKDD
AAYXX
ACGFO
AENEX
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CITATION
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
F5P
FA0
FRP
GX1
HYE
OK1
P2P
RNS
RPM
TR2
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c390t-bb9926943367c8f86eec621fa53c84fb8b62367e96ae4a34c56c841211bd5303
ISSN 1007-9327
2219-2840
IngestDate Thu Aug 21 18:25:07 EDT 2025
Fri Jul 11 04:13:42 EDT 2025
Mon Jul 21 05:38:20 EDT 2025
Thu Apr 24 22:52:57 EDT 2025
Tue Jul 01 02:11:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 8
Keywords Mixed adeno neuroendocrine carcinoma
Gallbladder
Mixed neuroendocrine–nonneuroendocrine neoplasms
Pancreas
Gastrointestinal system
Liver
Language English
License The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c390t-bb9926943367c8f86eec621fa53c84fb8b62367e96ae4a34c56c841211bd5303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Author contributions: Elpek GO performed the design of the article, obtained, analyzed and interpreted the data, and wrote the article.
Corresponding author: Gulsum Ozlem Elpek, MD, Professor, Pathology , Akdeniz University Medical School, Dumlupınar bulvarı, Antalya 07070, Turkey. elpek@akdeniz.edu.tr
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8900574
PMID 35317101
PQID 2642328274
PQPubID 23479
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8900574
proquest_miscellaneous_2642328274
pubmed_primary_35317101
crossref_primary_10_3748_wjg_v28_i8_794
crossref_citationtrail_10_3748_wjg_v28_i8_794
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-2-28
2022-Feb-28
20220228
PublicationDateYYYYMMDD 2022-02-28
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-2-28
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World J Gastroenterol
PublicationYear 2022
Publisher Baishideng Publishing Group Inc
Publisher_xml – name: Baishideng Publishing Group Inc
References B20
B21
B22
B23
B24
B25
B26
B27
B28
B29
B30
B31
B32
B33
B34
B35
B36
B37
B38
B39
B1
B2
B3
B4
B5
B6
B7
B8
B9
B40
B41
B42
B43
B44
B45
B46
B47
B48
B49
B50
B51
B52
B53
B54
B55
B56
B57
B58
B59
B109
B107
B108
B105
B106
B103
B104
B101
B102
B100
B60
B61
B62
B63
B64
B65
B66
B67
B68
B69
B114
B115
B112
B113
B110
B111
B70
B71
B72
B73
B74
B75
B76
B77
B78
B79
B80
B81
B82
B83
B84
B85
B86
B87
B88
B89
B90
B91
B92
B93
B94
B95
B96
B97
B10
B98
B11
B99
B12
B13
B14
B15
B16
B17
B18
B19
References_xml – ident: B36
  doi: 10.1186/s13000-019-0815-3
– ident: B42
  doi: 10.1530/ERC-14-0410
– ident: B110
  doi: 10.1007/s00428-012-1212-4
– ident: B24
  doi: 10.1159/000501200
– ident: B107
  doi: 10.1186/s12957-021-02187-5
– ident: B30
  doi: 10.1186/s12935-019-1031-7
– ident: B115
  doi: 10.1097/MD.0000000000023271
– ident: B76
  doi: 10.1001/jamanetworkopen.2021.14180
– ident: B100
  doi: 10.1097/MD.0000000000002156
– ident: B33
  doi: 10.1038/modpathol.2016.220
– ident: B5
  doi: 10.1186/s12967-020-02293-0
– ident: B7
  doi: 10.1007/978-3-642-59655-1
– ident: B80
  doi: 10.1097/PAS.0b013e31826399d8
– ident: B104
  doi: 10.1158/2159-8290.CD-14-0617
– ident: B78
  doi: 10.1097/01.pas.0000157974.05397.4f
– ident: B13
  doi: 10.1177/106689690401200204
– ident: B85
  doi: 10.1245/s10434-014-3725-3
– ident: B69
  doi: 10.3390/medsci9030047
– ident: B15
  doi: 10.3390/jcm9010273
– ident: B84
  doi: 10.21037/jgo.2018.11.08
– ident: B67
  doi: 10.1530/ERC-17-0557
– ident: B77
  doi: 10.1007/s12328-019-01009-2
– ident: B81
  doi: 10.1002/dc.23107
– ident: B39
  doi: 10.1002/path.5556
– ident: B54
  doi: 10.14670/HH-18-045
– ident: B53
  doi: 10.17235/reed.2016.4315/2016
– ident: B86
  doi: 10.1136/jcp.46.2.183
– ident: B103
  doi: 10.1016/s0002-9440(10)64917-6
– ident: B38
  doi: 10.1038/modpathol.2016.150
– ident: B9
– ident: B111
  doi: 10.1186/s40792-021-01152-4
– ident: B22
  doi: 10.3748/wjg.v21.i41.11740
– ident: B55
  doi: 10.1016/j.ejso.2019.08.002
– ident: B98
  doi: 10.1097/PAS.0000000000000169
– ident: B61
  doi: 10.1016/S0140-6736(15)00817-X
– ident: B56
  doi: 10.3389/fonc.2016.00148
– ident: B12
  doi: 10.32074/1591-951X-230
– ident: B43
  doi: 10.1097/MD.0000000000027348
– ident: B113
  doi: 10.1111/pin.12029
– ident: B18
– ident: B28
  doi: 10.1093/ajcp/aqw028
– ident: B40
  doi: 10.18632/oncotarget.18678
– ident: B74
  doi: 10.1177/0003134820950000
– ident: B51
  doi: 10.1097/MPA.0b013e318264d073
– ident: B26
– ident: B4
– ident: B101
  doi: 10.1016/j.pan.2020.11.020
– ident: B59
  doi: 10.1056/NEJMoa1316158
– ident: B63
  doi: 10.1186/s40792-018-0454-z
– ident: B73
  doi: 10.3389/fonc.2021.709097
– ident: B105
  doi: 10.1016/j.pathol.2020.01.437
– ident: B79
  doi: 10.1016/j.dld.2011.07.010
– ident: B32
– ident: B23
  doi: 10.1002/cncr.22179
– ident: B29
  doi: 10.1111/his.13975
– ident: B46
  doi: 10.1007/s00428-018-2366-5
– ident: B65
  doi: 10.1007/s00535-020-01756-x
– ident: B41
  doi: 10.1007/s00428-012-1348-2
– ident: B102
  doi: 10.1016/j.prp.2021.153593
– ident: B50
  doi: 10.1038/s41598-018-37707-z
– ident: B92
  doi: 10.1002/cam4.4031
– ident: B106
  doi: 10.3389/fsurg.2021.678853
– ident: B72
  doi: 10.1016/j.humpath.2020.12.008
– ident: B75
  doi: 10.3748/wjg.v27.i7.624
– ident: B45
– ident: B60
  doi: 10.1056/NEJMoa1607427
– ident: B95
  doi: 10.14309/crj.2018.39
– ident: B108
  doi: 10.1007/s005950300048
– ident: B99
  doi: 10.1186/s12893-019-0546-0
– ident: B91
  doi: 10.1007/s12328-021-01420-8
– ident: B3
  doi: 10.3748/wjg.v25.i39.5991
– ident: B89
  doi: 10.2169/internalmedicine.4609-20
– ident: B58
  doi: 10.1159/000443612
– ident: B47
  doi: 10.1016/j.jcma.2015.04.002
– ident: B52
  doi: 10.1007/s12328-015-0623-6
– ident: B64
  doi: 10.1177/000313482008600224
– ident: B88
  doi: 10.1177/1066896917752443
– ident: B35
  doi: 10.1016/j.humpath.2017.08.036
– ident: B10
  doi: 10.1007/s12022-018-9522-y
– ident: B1
  doi: 10.1016/j.humpath.2017.12.009
– ident: B70
  doi: 10.1016/S1590-8658(16)30195-5
– ident: B87
  doi: 10.1002/1097-0142(19810801)48:3<833::aid-cncr2820480328>3.0.co;2-z
– ident: B66
  doi: 10.1080/0284186X.2021.1903077
– ident: B112
  doi: 10.14740/gr1323
– ident: B48
  doi: 10.1002/cncr.28721
– ident: B109
  doi: 10.1016/S1726-4901(09)70400-9
– ident: B49
  doi: 10.1111/1751-2980.12752
– ident: B96
  doi: 10.1186/s12957-017-1157-9
– ident: B34
  doi: 10.5230/jgc.2018.18.e16
– ident: B93
  doi: 10.1016/j.prp.2020.152869
– ident: B83
  doi: 10.3389/fonc.2020.01660
– ident: B16
  doi: 10.1007/s12022-020-09605-6
– ident: B21
  doi: 10.1016/j.ejso.2020.08.022
– ident: B17
  doi: 10.1111/his.14178
– ident: B2
  doi: 10.1007/s12022-016-9432-9
– ident: B19
  doi: 10.3390/cancers4010011
– ident: B20
  doi: 10.1016/s0242-6498(05)86164-4
– ident: B31
  doi: 10.1038/s41379-021-00978-5
– ident: B71
  doi: 10.1097/01.lab.0000079006.91414.be
– ident: B62
  doi: 10.1016/j.critrevonc.2019.02.012
– ident: B8
– ident: B11
  doi: 10.1007/s00795-021-00294-6
– ident: B27
  doi: 10.1007/978-3-319-17235-4
– ident: B68
  doi: 10.2152/jmi.52.191
– ident: B114
  doi: 10.1200/PO.20.00487
– ident: B94
  doi: 10.3389/fmed.2015.00041
– ident: B57
  doi: 10.4274/balkanmedj.2017.1471
– ident: B82
  doi: 10.1016/j.ejso.2021.05.021
– ident: B6
  doi: 10.1007/s100249910040
– ident: B14
  doi: 10.1016/j.ejca.2014.08.004
– ident: B25
  doi: 10.1016/j.ando.2019.04.006
– ident: B97
  doi: 10.1136/bcr-2020-234855
– ident: B37
  doi: 10.1159/000369071
– ident: B44
  doi: 10.1159/000375449
– ident: B90
  doi: 10.1097/PAI.0000000000000969
SSID ssj0023352
Score 2.4579773
SecondaryResourceType review_article
Snippet Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs) of the digestive tract are a rare heterogeneous group of tumors that present many challenges in terms...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 794
SubjectTerms Adenocarcinoma
Aged
Biopsy
Gastrointestinal Tract - pathology
Humans
Male
Minireviews
Neuroendocrine Tumors - diagnosis
Title Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update
URI https://www.ncbi.nlm.nih.gov/pubmed/35317101
https://www.proquest.com/docview/2642328274
https://pubmed.ncbi.nlm.nih.gov/PMC8900574
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKeOEFDfGvMJCRkHhAKcRxHJu3CQ2mocFLEXtAimzH2YpKWrUJoD3xHfiGfBLu4iRNuiENXqLKuXNS38W-O9_9TMjTUNhch3EWuCRLAu44Dwyeb8KyUKvYwapi0FE8fi8OP_Kjk_hkNHrXy1qqSjOx55fWlfyPVKEN5IpVsv8g2a5TaIDfIF-4goTheiUZH89-4O494mu4IltYrORrsxeiAlNY-neAcLEEY_nruk0MONXrcrVAxAj40NEs9bjOTbCwWmI0oG-9-sybHtiE7wBhPVceywlZPx1153UdzJeunm7fVnMYmOcfzudNqLgJNICPuinc9nMjRjXB3Ev6k-eGoGqTb_1MmPizi9tF1eeubs_XiH0Dg_z9y-nkG5OTmZx0bH1g7K0Fq0sjBAcGe0iBPwX-dCZT4L9GrjPwGVgbumm8bywuq7e-m3_hETyR_8Xw-UML5YLbsZ092zNHprvkZuNH0H2vFLfIyBW3yedaIehQ7L9__rqgCrRTBbrIKagC3VYF6lXhFd0vqFeEO2T65mD6-jBojs8IbKReloExSmGdchSJxMpcCuesYGGu48hKnhtpBML3OSW04zriNhbQjpB_JovBsrlLduD13H1C80QZLRTT1jGesVjnsC5YGNIsVgb83zEJ2hFLbQMtjyeczNPLJTQmzzr6pQdV-Svlk1YAKcx7uJmlYYSqdQqGPDgDkiVAc88LpOsrgoUFLOdwTJKBqDoCxFQf3ilmZzW2ulRYns0fXPkNH5Ibm49lj-yUq8o9Aju1NI9r_fsDxlecIQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mixed+neuroendocrine%E2%80%93nonneuroendocrine+neoplasms+of+the+gastrointestinal+system%3A+An+update&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Elpek%2C+Gulsum+Ozlem&rft.date=2022-02-28&rft.issn=1007-9327&rft.volume=28&rft.issue=8&rft.spage=794&rft.epage=810&rft_id=info:doi/10.3748%2Fwjg.v28.i8.794&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v28_i8_794
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon